- Home
- ARVN vs KN Comparison
ARVN vs KN Comparison
Compare ARVN & KN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARVN
- KN
- Stock Information
- Founded
- ARVN 2015
- KN 1946
- Country
- ARVN United States
- KN United States
- Employees
- ARVN N/A
- KN N/A
- Industry
- ARVN Biotechnology: Pharmaceutical Preparations
- KN Consumer Electronics/Appliances
- Sector
- ARVN Health Care
- KN Consumer Staples
- Exchange
- ARVN Nasdaq
- KN Nasdaq
- Market Cap
- ARVN 1.7B
- KN 1.5B
- IPO Year
- ARVN 2018
- KN N/A
- Fundamental
- Price
- ARVN $25.11
- KN $18.57
- Analyst Decision
- ARVN Strong Buy
- KN Hold
- Analyst Count
- ARVN 13
- KN 1
- Target Price
- ARVN $61.08
- KN $19.00
- AVG Volume (30 Days)
- ARVN 718.1K
- KN 491.9K
- Earning Date
- ARVN 10-30-2024
- KN 10-24-2024
- Dividend Yield
- ARVN N/A
- KN N/A
- EPS Growth
- ARVN N/A
- KN N/A
- EPS
- ARVN N/A
- KN N/A
- Revenue
- ARVN $161,100,000.00
- KN $801,000,000.00
- Revenue This Year
- ARVN $237.44
- KN $0.38
- Revenue Next Year
- ARVN N/A
- KN N/A
- P/E Ratio
- ARVN N/A
- KN $34.97
- Revenue Growth
- ARVN 1.07
- KN 55.62
- 52 Week Low
- ARVN $21.17
- KN $14.97
- 52 Week High
- ARVN $53.08
- KN $19.73
- Technical
- Relative Strength Index (RSI)
- ARVN 48.81
- KN 56.07
- Support Level
- ARVN $21.17
- KN $17.70
- Resistance Level
- ARVN $28.70
- KN $19.49
- Average True Range (ATR)
- ARVN 1.72
- KN 0.48
- MACD
- ARVN -0.41
- KN -0.04
- Stochastic Oscillator
- ARVN 51.44
- KN 57.26
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About KN Knowles Corporation
Knowles Corp is engaged in the manufacturing of micro-acoustic microphones and balanced armature speakers, audio solutions, high-performance capacitors, and radio frequency filtering products. It operates in three segments; the Precision Devices segment specializes in the design and delivery of high-performance capacitor products and RF solutions, Medtech & Specialty Audio segment designs and manufactures microphones and balanced armature speakers used in applications and the Consumer MEMS Microphones segment designs and manufactures micro-electro-mechanical systems microphones and audio solutions used in applications. The majority of its revenue comes from the Consumer MEMS Microphones segment.